PHE - Corporate - Acute Drug Harms Surveillance and Early Warning System in UK Emergency Departments
What the buyer wrote
Public Health England (PHE) is seeking to commission an external partner with an existing system and / or capability to deliver an opioid and new psychoactive substances (NPS) clinical harms surveillance programme. The programme will: - rapidly detect any incident involving synthetic opioids in the heroin or cocaine markets; - monitor the emergence of a synthetic opioid market as seen in North America; - identify health harms associated with toxicity from emerging/new NPS, such as synthetic cannabinoids. Additional information: Proposals should be emailed to jade.palmer@phe.gov.uk and include the following documentation / information: 1. supporting statement setting out and est…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- PHE - Corporate - Acute Drug Harms Surveillance and Early Warning System in UK Emergency Departments
- How they are buying
- The buyer did not say
- Type
- services
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 2 Dec 2019
- Work ends
- 31 Mar 2021
- Kind of work
- Management consultancy
Who the buyer named
Sandeep Kapoor was the named contact on this notice.